Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteogenomics | 11 | 2024 | 109 | 2.360 |
Why?
|
| Estrogen Receptor alpha | 6 | 2023 | 743 | 0.950 |
Why?
|
| Breast Neoplasms | 17 | 2024 | 16244 | 0.860 |
Why?
|
| Endocytosis | 3 | 2011 | 239 | 0.710 |
Why?
|
| Receptors, Interleukin-5 | 2 | 2008 | 4 | 0.610 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2021 | 848 | 0.610 |
Why?
|
| Gene Fusion | 1 | 2018 | 214 | 0.560 |
Why?
|
| Receptors, Estrogen | 5 | 2024 | 2268 | 0.510 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2024 | 5421 | 0.470 |
Why?
|
| Cyclin-Dependent Kinase 6 | 3 | 2024 | 137 | 0.410 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2011 | 1 | 0.400 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 2024 | 212 | 0.400 |
Why?
|
| Lysine | 2 | 2011 | 428 | 0.390 |
Why?
|
| Janus Kinase 1 | 1 | 2011 | 125 | 0.370 |
Why?
|
| Ubiquitination | 2 | 2021 | 577 | 0.360 |
Why?
|
| Eosinophils | 2 | 2008 | 168 | 0.350 |
Why?
|
| Triple Negative Breast Neoplasms | 4 | 2024 | 1381 | 0.340 |
Why?
|
| Proteomics | 9 | 2024 | 1437 | 0.320 |
Why?
|
| Transferrin | 1 | 2008 | 76 | 0.310 |
Why?
|
| Signal Transduction | 8 | 2021 | 12223 | 0.290 |
Why?
|
| Janus Kinase 2 | 1 | 2011 | 754 | 0.280 |
Why?
|
| Neoplasms | 5 | 2024 | 15930 | 0.260 |
Why?
|
| Antineoplastic Agents | 4 | 2024 | 14653 | 0.260 |
Why?
|
| src-Family Kinases | 2 | 2016 | 487 | 0.260 |
Why?
|
| Janus Kinases | 1 | 2007 | 175 | 0.260 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2021 | 1004 | 0.250 |
Why?
|
| Ubiquitin | 1 | 2007 | 335 | 0.240 |
Why?
|
| Precision Medicine | 2 | 2023 | 1207 | 0.230 |
Why?
|
| Neurofibromin 1 | 2 | 2023 | 84 | 0.220 |
Why?
|
| Phenylthiohydantoin | 1 | 2024 | 106 | 0.220 |
Why?
|
| Molecular Targeted Therapy | 3 | 2024 | 2400 | 0.210 |
Why?
|
| Down-Regulation | 1 | 2007 | 2106 | 0.190 |
Why?
|
| Mass Spectrometry | 2 | 2021 | 726 | 0.180 |
Why?
|
| Humans | 33 | 2024 | 272091 | 0.180 |
Why?
|
| Mutation | 7 | 2023 | 15944 | 0.170 |
Why?
|
| Proteome | 1 | 2023 | 573 | 0.170 |
Why?
|
| Metformin | 1 | 2023 | 395 | 0.170 |
Why?
|
| Nitriles | 1 | 2024 | 945 | 0.160 |
Why?
|
| Female | 22 | 2024 | 149288 | 0.160 |
Why?
|
| Claudins | 1 | 2018 | 56 | 0.160 |
Why?
|
| Benzamides | 1 | 2024 | 1882 | 0.160 |
Why?
|
| Receptors, Androgen | 1 | 2024 | 909 | 0.160 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2022 | 1237 | 0.150 |
Why?
|
| MutL Proteins | 1 | 2017 | 30 | 0.150 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 695 | 0.150 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2017 | 131 | 0.140 |
Why?
|
| Paclitaxel | 1 | 2024 | 2099 | 0.140 |
Why?
|
| Software | 1 | 2024 | 1387 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2024 | 2290 | 0.140 |
Why?
|
| Mitosis | 1 | 2018 | 692 | 0.130 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 802 | 0.130 |
Why?
|
| Genomics | 4 | 2023 | 2830 | 0.130 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 5187 | 0.130 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 3026 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2021 | 7302 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2018 | 561 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2016 | 185 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2020 | 1037 | 0.120 |
Why?
|
| Protein Binding | 3 | 2021 | 3528 | 0.110 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 1389 | 0.110 |
Why?
|
| Neoadjuvant Therapy | 2 | 2024 | 5213 | 0.110 |
Why?
|
| Phosphorylation | 4 | 2023 | 4984 | 0.110 |
Why?
|
| Transfection | 1 | 2018 | 3166 | 0.110 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 14881 | 0.110 |
Why?
|
| MCF-7 Cells | 3 | 2020 | 554 | 0.110 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 1014 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1556 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 9101 | 0.090 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 1335 | 0.090 |
Why?
|
| Endosomes | 1 | 2011 | 105 | 0.090 |
Why?
|
| Cell Movement | 1 | 2018 | 2504 | 0.090 |
Why?
|
| Protein Transport | 1 | 2011 | 739 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2024 | 3929 | 0.080 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 2008 | 8 | 0.080 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 26 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2021 | 4360 | 0.080 |
Why?
|
| Clathrin | 1 | 2008 | 37 | 0.080 |
Why?
|
| Cholera Toxin | 1 | 2008 | 69 | 0.080 |
Why?
|
| Interleukin-5 | 1 | 2008 | 69 | 0.080 |
Why?
|
| Prognosis | 2 | 2023 | 22555 | 0.080 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2008 | 123 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 201 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2011 | 1470 | 0.070 |
Why?
|
| p21-Activated Kinases | 2 | 2018 | 132 | 0.070 |
Why?
|
| Tyrphostins | 1 | 2007 | 112 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 4811 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2024 | 10750 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 5603 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2023 | 2150 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 16612 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2008 | 900 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2007 | 719 | 0.060 |
Why?
|
| Animals | 8 | 2024 | 62827 | 0.060 |
Why?
|
| Protein Kinases | 2 | 2020 | 919 | 0.060 |
Why?
|
| Immunotherapy | 3 | 2024 | 3546 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 599 | 0.060 |
Why?
|
| Phosphopeptides | 1 | 2023 | 73 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2023 | 48 | 0.060 |
Why?
|
| NFI Transcription Factors | 1 | 2023 | 78 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 4964 | 0.050 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 64 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2023 | 6489 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2023 | 33909 | 0.050 |
Why?
|
| Purines | 1 | 2023 | 275 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2008 | 3078 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2022 | 2319 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2023 | 445 | 0.050 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2021 | 109 | 0.050 |
Why?
|
| APOBEC Deaminases | 1 | 2020 | 6 | 0.050 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 57 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 384 | 0.050 |
Why?
|
| Mice | 5 | 2024 | 36056 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 685 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2022 | 341 | 0.040 |
Why?
|
| Acetylation | 1 | 2021 | 517 | 0.040 |
Why?
|
| ErbB Receptors | 2 | 2021 | 2383 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 120 | 0.040 |
Why?
|
| beta Catenin | 1 | 2023 | 691 | 0.040 |
Why?
|
| Aged | 5 | 2024 | 73517 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 1966 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2020 | 342 | 0.040 |
Why?
|
| Carboplatin | 1 | 2022 | 879 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 416 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2020 | 524 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2018 | 43 | 0.040 |
Why?
|
| Estrogen Antagonists | 1 | 2020 | 219 | 0.040 |
Why?
|
| Cell Line | 1 | 2007 | 5433 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 172 | 0.040 |
Why?
|
| Cell Division | 1 | 2023 | 2711 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 1074 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 122 | 0.040 |
Why?
|
| Apoptosis | 2 | 2024 | 7837 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 12012 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 2 | 2020 | 2649 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2007 | 5788 | 0.040 |
Why?
|
| Peptides | 1 | 2024 | 1529 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 194 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 132 | 0.040 |
Why?
|
| Models, Biological | 1 | 2007 | 3223 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 167 | 0.040 |
Why?
|
| Adult | 5 | 2024 | 81933 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 260 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2024 | 1590 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1409 | 0.040 |
Why?
|
| Pyridines | 1 | 2024 | 1312 | 0.040 |
Why?
|
| Middle Aged | 5 | 2024 | 90460 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 3671 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 9500 | 0.040 |
Why?
|
| Metabolomics | 1 | 2020 | 507 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 31066 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 1842 | 0.030 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2016 | 10 | 0.030 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2016 | 53 | 0.030 |
Why?
|
| Heterografts | 1 | 2018 | 745 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 2085 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2020 | 906 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2020 | 1851 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2016 | 116 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 1085 | 0.030 |
Why?
|
| ras Proteins | 1 | 2020 | 802 | 0.030 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2019 | 443 | 0.030 |
Why?
|
| Piperazines | 1 | 2024 | 2152 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 196 | 0.030 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 314 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2023 | 2139 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 274 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 322 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 1740 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 4071 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 1566 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 5804 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 531 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 1146 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 557 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 3856 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 2496 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 1950 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 487 | 0.030 |
Why?
|
| DNA Repair | 1 | 2020 | 1912 | 0.030 |
Why?
|
| DNA Damage | 1 | 2020 | 1989 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 1288 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2022 | 2975 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 1056 | 0.020 |
Why?
|
| Disease Progression | 1 | 2022 | 6911 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2018 | 1730 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2016 | 1230 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 7476 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 3417 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3363 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 1720 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2008 | 65 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2008 | 53 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 13410 | 0.020 |
Why?
|
| Turner Syndrome | 1 | 2008 | 65 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12534 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 3472 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 426 | 0.020 |
Why?
|
| Karyotyping | 1 | 2008 | 1064 | 0.020 |
Why?
|
| Exons | 1 | 2008 | 1388 | 0.020 |
Why?
|
| Monocytes | 1 | 2008 | 789 | 0.020 |
Why?
|
| Male | 3 | 2021 | 129089 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 22142 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 4267 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 17056 | 0.010 |
Why?
|